Abstract
Inhibition of cellular differentiation is one of the well-known biological activities of c-Myc-family proteins. We show here that Myc represses differentiation-induced expression of the cyclin-dependent kinase (CDK) inhibitor p21CIP1 (CDKN1A, p21), known to play an important role in cell fate decisions during growth and differentiation, in hematopoietic cells. Our results demonstrate that the c-Myc-responsive region is situated in the p21 core promoter. c-Myc binds to this region in vitro and in vivo through interaction with the initiator-binding Zn-finger transcription factor Miz-1, which associates directly with the promoter. Association of Myc with the promoter in vivo correlates inversely with p21 expression. Using mutants of c-Myc with impaired binding to Miz-1, our results further show that repression of p21 promoter/reporters as well as the endogenous p21 gene by Myc depends on interaction with Miz-1. Expression of Miz-1 increases during hematopoietic differentiation and Miz-1 activates the p21 promoter under conditions of low Myc levels, indicating a positive role for free Miz-1 in this process. In conclusion, repression of differentia-tion-induced p21 expression through Miz-1 may be an important mechanism by which Myc blocks diffe-rentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Amati B, Frank SR, Donjerkovic D and Taubert S . (2001). Biochim. Biophys. Acta, 1471, M135–M145.
Bahram F, Wu S, Oberg F, Luscher B and Larsson L-G . (1999). Blood, 93, 3900–3912.
Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M and Luscher, B . (2001). Genes Dev., 15, 2042–2047.
Ceballos E, Delgado MD, Gutierrez P, Richard C, Muller D, Eilers M, Ehinger M, Gullberg U and Leon J . (2000). Oncogene, 19, 2194–2204.
Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M and Scadden DT . (2000). Science, 287, 1804–1808.
Claassen GF and Hann SR . (2000). Proc. Natl. Acad. Sci. USA, 97, 9498–9503.
Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR . (2000). Proc. Natl. Acad. Sci. USA, 97, 3260–3265.
Delgado MD, Lerga A, Canelles M, Gomez-Casares MT and Leon J . (1995). Oncogene, 10, 1659–1665.
Delgado MD, Vaque JP, Arozarena I, Lopez-Ilasaca MA, Martinez C, Crespo P and Leon J . (2000). Oncogene, 19, 783–790.
Eberhardy SR, D'Cunha CA and Farnham PJ . (2000). J. Biol. Chem., 275, 33798–33805.
Feng XH, Liang YY, Liang M, Zhai W and Lin X . (2002). Mol. Cell, 9, 133–143.
Frank SR, Schroeder M, Fernandez P, Taubert S and Amati B . (2001). Genes Dev., 15, 2069–2082.
Gartel AL and Tyner AL . (1999). Exp. Cell Res., 246, 280–289.
Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F and Tyner AL . (2001). Proc. Natl. Acad. Sci. USA, 98, 4510–4515.
Grandori C, Cowley SM, James LP and Eisenman RN . (2000). Annu. Rev. Cell Dev. Biol., 16, 653–699.
Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A and Massague J . (2000). Cell, 100, 229–240.
Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz H-P, Haenel F and Eilers M . (2002). Mol. Cell, 10, 509–521.
Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fisher PB . (1994). Oncogene, 9, 3397–3406.
James L and Eisenman RN . (2002). Proc. Natl. Acad. Sci. USA, 99, 10429–10434.
Larsson L-G, Ivhed I, Gidlund M, Pettersson U, Vennstrom B and Nilsson K . (1988). Proc. Natl. Acad. Sci. USA, 85, 2638–2642.
Levens D . (2002). Proc. Natl. Acad. Sci. USA, 99, 5757–5759.
Li LH, Nerlov C, Prendergast G, MacGregor D and Ziff EB . (1994). EMBO J., 13, 4070–4079.
Liu M, Lee MH, Cohen M, Bommakanti M and Freedman LP . (1996). Genes Dev., 10, 142–153.
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD and Cole MD . (1998). Cell, 94, 363–374.
McMahon SB, Wood MA and Cole MD . (2000). Mol. Cell Biol., 20, 556–562.
Missero C, Di Cunto F, Kiyokawa H, Koff A and Dotto GP . (1996). Genes Dev., 10, 3065–3075.
Mitchell KO and El-Deiry WS . (1999). Cell Growth Differ., 10, 223–230.
O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, Meltzer P and DePinho RA . (2000). Nat. Genet., 24, 113–119.
Peukert K, Staller P, Schneider A, Carmichael G, Hanel F and Eilers M . (1997). EMBO J., 16, 5672–5686.
Ricci AR, Genereaux J and Brandl CJ . (2002). Mol. Cell Biol., 22, 4033–4042.
Seoane J, Pouponnot C, Staller P, Schader M, Eilers M and Massague J . (2001). Nat. Cell Biol., 3, 400–408.
Sherr CJ and Roberts JM . (1999). Genes Dev., 13, 1501–1512.
Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Moroy T, Bartek J, Massague J, Hanel F and Eilers M . (2001). Nat. Cell. Biol., 3, 392–399.
Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and el-Houseini ME . (1994). Oncogene 9, 3389–3396.
Steinman RA . (2002). Oncogene 21, 3403–3413.
Warner BJ, Blain SW, Seoane J and Massague J . (1999). Mol. Cell Biol., 19, 5913–5922.
Wu KJ, Polack A and Dalla-Favera R . (1999). Science, 283, 676–679.
Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP and Sonenshein GE . (2001). Oncogene, 20, 1688–1702.
Zeng YX, Somasundaram K and el-Deiry WS . (1997). Nat. Genet., 15, 78–82.
Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV and Koff A . (2001). EMBO Rep., 2, 27–34.
Zhang P, Wong C, Liu D, Finegold M, Harper JW and Elledge SJ . (1999). Genes Dev., 13, 213–224.
Acknowledgements
We thank Drs WS El-Deiry, B Lüscher, P Staller, X-F Wang, G Westin, B Westermark and J Ziegelbauer for reagents. We also thank Dr J Botling, Åsa Böker and A Castell for experimental support, and Drs D Balciunas, D Grander, B Lüscher, A Moustakas, F Öberg, H Ronne, C Svensson and G Westin for valuable discussions. This work was supported by grants from the Swedish Cancer Society, Deutsche Forschungsmeinschaft, and Grants PM98-109 and FD97-1987 from the Spanish Government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, S., Cetinkaya, C., Munoz-Alonso, M. et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22, 351–360 (2003). https://doi.org/10.1038/sj.onc.1206145
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1206145
Keywords
This article is cited by
-
PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma
Nature Communications (2024)
-
NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Journal of Translational Medicine (2023)
-
Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma
Diagnostic Pathology (2023)
-
HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection
Nature Communications (2022)
-
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Journal of Hematology & Oncology (2021)


